{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:57:44Z","timestamp":1787507864762,"version":"build-2736575974"},"reference-count":35,"publisher":"Tech Science Press","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1339,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1747-0803.2011.00611.x","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T07:57:32Z","timestamp":1326182252000},"page":"3-11","source":"Crossref","is-referenced-by-count":51,"title":["Can \u201cInoperable\u201d Congenital Heart Defects Become Operable in Patients with Pulmonary Arterial Hypertension? Dream or Reality?"],"prefix":"10.32604","volume":"7","author":[{"given":"Maurice","family":"Beghetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazzareno","family":"Gali\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ccd.21446","article-title":"Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance","volume":"71","author":"Viswanathan","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/hrt.2006.114660","article-title":"Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure","volume":"94","author":"Balint","year":"2008","journal-title":"Heart"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2008.02.004","article-title":"Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy","volume":"129","author":"Dimopoulos","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/1010-7940(91)90209-3","article-title":"Is lung biopsy useful in surgical decision making in congenital heart disease?","volume":"5","author":"Frescura","year":"1991","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S1047951109990771","article-title":"Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease","volume":"19","author":"Lopes","year":"2009","journal-title":"Cardiol Young"},{"issue":"2","key":"10.1111\/j.1747-0803.2011.00611.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/PCC.0b013e3181d10cce","article-title":"Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?","volume":"11","author":"Giglia","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB8|cit8","first-page":"161","article-title":"Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance","volume":"55","author":"Kannan","year":"2003","journal-title":"Indian Heart J"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","article-title":"Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease","volume":"119","author":"Smadja","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jacc.2006.09.049","article-title":"Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease","volume":"49","author":"L\u00e9vy","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00246-010-9674-0","article-title":"Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease","volume":"31","author":"Smadja","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.CIR.0000053443.27512.33","article-title":"Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension","volume":"107","author":"Rondelet","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0070-2153(05)67008-1","article-title":"Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension","volume":"67","author":"Theo Schermuly","year":"2005","journal-title":"Curr Top Dev Biol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"23","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2009.04.037","article-title":"Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis","volume":"144","author":"Berger","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ccd.21877","article-title":"Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension","volume":"73","author":"Hirabayashi","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jtcvs.2008.03.064","article-title":"Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report","volume":"137","author":"Hoetzenecker","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.healun.2007.09.001","article-title":"Bosentan treatment in an adult with pulmonary hypertension due to patent ductus arteriosus permits surgical repair","volume":"26","author":"Mitropoulos","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijcard.2006.03.080","article-title":"Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension","volume":"116","author":"Ussia","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2005.05.062","article-title":"Atrial septal defect closure in a patient with \u201cirreversible\u201d pulmonary hypertensive arteriopathy","volume":"110","author":"Schwerzmann","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.healun.2004.02.004","article-title":"Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol","volume":"24","author":"Frost","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.athoracsur.2009.10.027","article-title":"Repair of atrial septal defect with Eisenmenger syndrome after long-term sildenafil therapy","volume":"89","author":"Kim","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1183\/09059180.00007610","article-title":"Sinus venosus atrial septal defect in a 31-year-old female patient: a case for surgical repair","volume":"19","author":"Gatzoulis","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2010.04.094","article-title":"Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease","volume":"151","author":"Huang","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11748-004-0112-1","article-title":"Atrial septal defect with borderline pulmonary vascular disease: surgery and long-term oral prostacyclin therapy for recalcitrant pulmonary hypertension","volume":"52","author":"Yamauchi","year":"2004","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.ijcard.2006.10.023","article-title":"Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder","volume":"117","author":"Eicken","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00611.x-BIB35|cit35","first-page":"174","article-title":"Current era survival of patients with pulmonary arterial hypertension (PAH) associate with congenital heart disease (CHD)","volume":"32","author":"Palazzini","year":"2011","journal-title":"Eur Heart J"}],"container-title":["Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0803.2011.00611.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T18:01:08Z","timestamp":1588010468000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1747-0803.2011.00611.x"}},"subtitle":["Operability of Patients with PAH-CHD"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1747-0803.2011.00611.x","relation":{},"ISSN":["1747-079X"],"issn-type":[{"value":"1747-079X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}